Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41 USD | +1.69% | -1.91% | +15.23% |
Financials (USD)
Sales 2024 * | 12.12M | Sales 2025 * | 93.57M | Capitalization | 3.1B |
---|---|---|---|---|---|
Net income 2024 * | -176M | Net income 2025 * | -143M | EV / Sales 2024 * | 186 x |
Net cash position 2024 * | 854M | Net cash position 2025 * | 663M | EV / Sales 2025 * | 26.1 x |
P/E ratio 2024 * |
-17.4
x | P/E ratio 2025 * |
-21.6
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.89% |
Latest transcript on IDEAYA Biosciences, Inc.
1 day | +1.69% | ||
1 week | -1.91% | ||
Current month | +0.86% | ||
1 month | +10.42% | ||
3 months | -7.43% | ||
6 months | +34.43% | ||
Current year | +15.23% |
Managers | Title | Age | Since |
---|---|---|---|
Yujiro Hata
FOU | Founder | 49 | 15-05-31 |
Andres Briseno
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Michael White
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
CHM | Chairman | 65 | 16-05-05 |
Wendy Yarno
BRD | Director/Board Member | 69 | 19-12-16 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 41 | +1.69% | 1,505,818 |
24-05-20 | 40.32 | -0.44% | 596,585 |
24-05-17 | 40.5 | -2.48% | 761,258 |
24-05-16 | 41.53 | -2.14% | 532,228 |
24-05-15 | 42.44 | +1.53% | 762,107 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.23% | 3.1B | |
+44.48% | 55.07B | |
+43.57% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- IDYA Stock